VF
FULC icon

Virtu Financial’s Fulcrum Therapeutics FULC Stock Holding History

Virtu Financial’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61K Buy
+16,596
New +$101K ﹤0.01% 1193
2025
Q2 		– Sell
-13,564
Closed -$39K – 1664
2025
Q1 		$39K Buy
+13,564
New +$49.8K ﹤0.01% 1041
2023
Q2 		– Sell
-31,104
Closed -$89K – 1686
2023
Q1 		$89K Buy
+31,104
New +$279K 0.01% 1009

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Virtu Financial's FULC Position: Q2 2026 in Review

Virtu Financial opened a new position in Fulcrum Therapeutics (FULC) in Q2 2026: 16,596 shares worth $61K. The stake represents ﹤0.01% of the portfolio and ranks #1193 among its holdings. This is a return to the name: Virtu Financial previously reported a position in FULC as recently as Q1 2025.

Virtu Financial first reported a position in FULC in Q1 2023 and has held it in 3 quarters since. The position peaked at $89K in Q1 2023. 154 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Virtu Financial held 16,596 shares of Fulcrum Therapeutics worth $61K as of Q2 2026.
  • Fulcrum Therapeutics was a new Virtu Financial position in Q2 2026.
  • Fulcrum Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1193 holding.
  • Virtu Financial first reported a position in Fulcrum Therapeutics in Q1 2023 and has held it in 3 quarters since.
  • Virtu Financial's Fulcrum Therapeutics position peaked at $89K in Q1 2023.
  • 154 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.